About Ovarian cancer research fund alliance(ocrfa)
Ovarian Cancer Research Alliance (OCRA) is a non-profit organization that is dedicated to advancing ovarian cancer research while providing support to women and their families. The organization was founded in 1994 as the Ovarian Cancer Research Fund, and it has since grown into the largest global nonprofit focused on ovarian cancer.
The mission of OCRA is to fund scientific research that will lead to more effective ways of diagnosing, treating, and ultimately curing ovarian cancer. The organization also provides support services for women who have been diagnosed with ovarian cancer, as well as their families.
One of the key initiatives of OCRA is its research program. The organization funds cutting-edge research projects that are aimed at improving our understanding of ovarian cancer and developing new treatments for the disease. Through its research program, OCRA has made significant contributions to our knowledge of ovarian cancer biology and treatment options.
In addition to its research program, OCRA also provides a range of support services for women with ovarian cancer. These services include educational resources about the disease, financial assistance programs for patients who are struggling with medical bills, and advocacy efforts aimed at improving access to care for women with ovarian cancer.
Another important aspect of OCRA's work is its public awareness campaigns. The organization works tirelessly to raise awareness about the signs and symptoms of ovarian cancer so that more women can be diagnosed early when treatment options are most effective. Through its outreach efforts, OCRA has helped thousands of women learn about this deadly disease and take steps to protect themselves from it.
Overall, Ovarian Cancer Research Alliance (OCRA) plays a critical role in advancing our understanding of this devastating disease while providing much-needed support services for patients and their families. With continued funding from donors around the world, we can look forward to even greater progress in the fight against ovarian cancer in years ahead.